EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRW and the CUSIP is G3141W122. A total of 20 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1 | 0.0% | 22,697 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -99.9% | 22,697 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 22,697 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -50.0% | 22,697 | 0.0% | 0.00% | – |
| Q1 2022 | $4,000 | -69.2% | 22,697 | 0.0% | 0.00% | – |
| Q4 2021 | $13,000 | -27.8% | 22,697 | 0.0% | 0.00% | – |
| Q3 2021 | $18,000 | -25.0% | 22,697 | 0.0% | 0.00% | – |
| Q2 2021 | $24,000 | +71.4% | 22,697 | +42.5% | 0.00% | – |
| Q1 2021 | $14,000 | – | 15,931 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 66,666 | $660,000 | 0.02% |
| Radcliffe Capital Management, L.P. | 33,333 | $330,000 | 0.01% |
| Altium Capital Management LP | 133,333 | $9,000 | 0.00% |
| Arena Investors LP | 94,516 | $6,000 | 0.00% |
| Granite Point Capital Management, L.P. | 133,332 | $9,000 | 0.00% |
| COWEN AND COMPANY, LLC | 122,257 | $8,000 | 0.00% |
| 683 Capital Management, LLC | 200,000 | $13,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GLAZER CAPITAL, LLC | 11,584 | $0 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 26,666 | $2,000 | 0.00% |